Tradução, Adaptação e Validação da Escala Jones Dependency Tool

A avaliação do grau de dependência dos utentes é um dos aspectos que contribui para a melhoria dos cuidados, dado que permite uma melhor adequação dos recursos humanos às situações vivenciadas no quotidiano dos serviços de urgência. A carga de trabalho em enfermagem está estreitamente relacionada com o grau de dependência, pelo que a sua avaliação assume-se como um elemento fundamental numa politica de gestão de qualidade. Com o intuito de avaliar, numa fase inicial, o grau de dependência dos utentes que recorrem aos serviços de urgência foi criada uma escala – Jones Dependency Tool (JDT) – sendo que o objectivo major é a avaliação da carga de trabalho em Enfermagem relacionando com o grau de dependência dos utentes. O presente estudo visa traduzir, adaptar e validar para Portugal o referido instrumento. O estudo encontra-se dividido em duas partes. A primeira constituída pela tradução e adaptação cultural da JDT para língua portuguesa e a segunda, pela análise da fidelidade e da validade do instrumento. O processo de validação para a língua portuguesa ocorreu numa amostra de 129 utentes de dois serviços de urgência da região de lisboa. Através dos testes estatísticos realizados, a versão Portuguesa revelou-se um instrumento confiável e válido para a realização do grau de dependência dos utentes que recorrem ao serviço de urgência.

Effect of Efavirenz on High-Density Lipoprotein Antioxidant Properties in HIV-Infected Patients

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * In previous work, we showed a long-term and concentration-dependent beneficial effect of the non-nucleoside reverse transcriptase inhibitor efavirenz (EFV) on high-density lipoproteins (HDL) in human immunodeficiency virus (HIV)-infected patients. * Furthermore, it has been suggested that instead of the current practice of only measuring HDL-chelesterol values, the evaluation of HDL function, namely its antioxidant properties, might be an improved tool for identifying subjects at increased risk for cardiovascular events. * Paraoxonase-1 (PON-1) is an enzyme associated with HDL that is responsible for HDL antioxidant function. WHAT THIS STUDY ADDS: * In the present work, we studied the effect of EFV on the activity of PON-1 and showed, for the first time, that EFV-based antiretroviral therapy is associated with a better antioxidant function, i.e. with a higher PON-1 activity. AIMS: A long-term and concentration-dependent beneficial effect of efavirenz (EFV) on cholesterol associated with high-density lipoprotein (HDL-c) in human immunodeficiency virus (HIV)-infected patients has been documented. Furthermore, it has been suggested that, instead of the current practice of only measuring HDL-c values, the evaluation of HDL quality might be an improved tool for identifying subjects at increased risk of cardiovascular events. Paraoxonase-1 (PON-1) is an enzyme associated with HDL that is involved in the onset of cardiovascular disease and responsible for HDL antioxidant function. The aim of the present study was to investigate the effect of EFV on the circulating activity of PON-1 in HIV-infected patients. METHODS: The patients included were adults with a documented HIV-1 infection, nontreated or treated with antiretroviral regimens including EFV 600 mg once daily as first therapeutic regimen for at least 3 months. The influence of treatment with EFV, HDL-c and CD4 cell count on PON-1 activity was analysed. RESULTS: HIV-infected White patients treated with EFV had higher PON-1 activity [77.35 U l(-1) (65.66, 89.04)] (P < 0.05) and higher PON-1 activity : HDL-c ratio [1.88 (1.49, 2.28)] (P < 0.01) than untreated patients. PON-1 activity was higher in Black patients (P < 0.001) and in patients with a CD4 cell count >500 cells ml(-1) (P= 0.0120). CONCLUSIONS: EFV-based antiretroviral regimens are associated with HDL particles with a better antioxidant function, i.e. with a higher PON-1 activity. The PON-1 activity of Black patients is higher than that found in Whites regardless of treatment. Ethnicity should be taken into consideration when studying drug effects on PON-1 activity.